Oncology Practices “Left Guessing” About Drug Fee Concerns

Published On: May 21st, 2024Categories: Latest News, News & Updates

Community oncology practices are “left guessing” when it comes to “noticeable” challenges surrounding changes with direct and indirect remuneration (DIR) fees, says Kathy Oubre, MS, CEO of Pontchartrain Cancer Center in Louisiana.

Community oncology practices are “left guessing” when it comes to “noticeable” challenges surrounding changes with direct and indirect remuneration (DIR) fees, says Kathy Oubre, MS, CEO of Pontchartrain Cancer Center in Louisiana.